C4 Therapeutics Inc (CCCC) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
C4 Therapeutics Inc   (NASDAQ: CCCC)

C4 Therapeutics Inc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CCCC Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 0 % 71.11 % 65.43 % 46.08 %
Gross Margin (Q2 TTM) 81.05 % 73.3 % 65.99 % 46.3 %
Gross Profit Margin 5 Yr. Avg. - 70.97 % 65.55 % 48.95 %
EBITDA Margin (Q2 MRQ) 4.4 % 20.77 % 18.99 % 20.49 %
EBITDA Margin (Q2 TTM) -239.04 % 26.4 % 21.01 % 20.13 %
EBITDA Margin 5 Yr. Avg. --381.96 % 22.79 % 31.38 % 23.41 %
Operating Margin (Q2 MRQ) -397.88 % 11.42 % 16.58 % 16.05 %
Operating Margin (Q2 TTM) -318.97 % 15.3 % 17.81 % 16.34 %
Operating Margin 5 Yr. Avg. --384.49 % 6.03 % 14.33 % 19.26 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 7.52 % 10.94 % 13.96 %
Pre-Tax Profit Margin (Q2 TTM) -221.64 % 14 % 12.79 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 9.88 % 10.37 % 13.52 %
Net Margin (Q2 MRQ) -355.9 % 2.76 % 8.15 % 11.42 %
Net Margin (Q2 TTM) -289.44 % 10.35 % 9.94 % 10.76 %
Net Margin 5 Yr. Avg. - 6.58 % 6.08 % 10.8 %



Business Segment Profit Margin